Beijing Tongren Hospital sells data for drug R&D
Share - WeChat
In a national first for China's digital healthcare market, Beijing Tongren Hospital has successfully completed the country's first legally compliant sale of a massive ophthalmic patient dataset to commercial pharmaceutical companies.
Known for its leading expertise in treating eye diseases, the hospital has formed an ophthalmic database built upon a population of 100,000 people "during more than a decade of in-depth follow-up research and long-term accumulated clinical data", according to the hospital.
It contains data of 30 million entries, with 873 professional quantitative parameters, 188,000 fundus images and 3.5 million OCT images.


















